Shanghai Municipal Science and Technology Commission Holds Roundtable Discussion with Foreign-funded R&D Institutions in Shanghai

On March 31, the Shanghai Municipal Science and Technology Commission jointly organized a roundtable exchange meeting with the China-EU Chamber of Commerce to serve foreign-funded R&D institutions in Shanghai. Representatives from the China-EU Chamber of Commerce, six foreign-funded R&D institutions including Novartis, bioMérieux, Siemens Healthineers, DSM-Firmenich, GlaxoSmithKline, and Novo Nordisk, as well as relevant departments of the Municipal Science and Technology Commission and colleagues from the Shanghai Science and Technology Exchange Center, attended the event. The Shanghai Municipal Science and Technology Commission responded to the opinions and suggestions of the enterprises, stating that they will further strengthen communication, resource docking with foreign-funded R&D institutions, fully support policies, enhance innovation collaboration, optimize the innovation ecosystem, and assist Shanghai’s biopharmaceutical industry in high-quality development. (People’s Finance News)